SC
HGEN

Sculptor Capital’s HUMANIGEN, INC. HGEN Stock Holding History

Sculptor Capital’s Portfolio HGEN Stock Details HGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-38,800
Closed -$117K – 1286
2022
Q1 		$117K Hold
38,800
– – ﹤0.01% 921
2021
Q4 		$144K Sell
38,800
-8,700
-18% -$50.9K ﹤0.01% 909
2021
Q3 		$282K Buy
47,500
+35,500
+296% +$499K ﹤0.01% 702
2021
Q2 		$209K Hold
12,000
– – ﹤0.01% 744
2021
Q1 		$229K Buy
+12,000
New +$219K ﹤0.01% 576

Other funds holding HGEN

VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital's HGEN Position: Q2 2022 in Review

Sculptor Capital sold out of HUMANIGEN, INC. (HGEN) in Q2 2022, closing a stake of 38,800 shares — an estimated $117K sold.

Sculptor Capital first reported a position in HGEN in Q1 2021 and held it in 5 quarters. The position peaked at $282K in Q3 2021. 65 funds tracked by Wall St. Rank hold HGEN as of Q2 2022.

  • Sculptor Capital reported no remaining HUMANIGEN, INC. position as of Q2 2022 after selling out during the quarter.
  • Sculptor Capital sold 38,800 HUMANIGEN, INC. shares in Q2 2022, an estimated $117K.
  • Sculptor Capital first reported a position in HUMANIGEN, INC. in Q1 2021 and held it in 5 quarters.
  • Sculptor Capital's HUMANIGEN, INC. position peaked at $282K in Q3 2021.
  • 65 funds tracked by Wall St. Rank held HUMANIGEN, INC. as of Q2 2022.

Based on Sculptor Capital's 13F filing for Q2 2022, filed 12 Aug 2022.